US OptionsDetailed Quotes
CLRB241220C5000
- 0.05
- 0.000.00%
15min DelayClose Nov 22 16:00 ET
0.00High0.00Low
0.05Open0.05Pre Close0 Volume151 Open Interest5.00Strike Price0.00Turnover265.63%IV219.62%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier28DDays to Expiry0.05Extrinsic Value100Contract SizeAmericanOptions Type0.1163Delta0.1684Gamma31.60Leverage Ratio-0.0040Theta0.0001Rho3.68Eff Leverage0.0009Vega
Cellectar BioSciences Stock Discussion
Northstar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225)
Cellectar BioSciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Laurence W. Lytton(9.99%)
Cellectar Biosciences and Northstar Medical Radioisotopes Announce Partnership for Supply of Actinium-225
2 MINUTES AGO, 8:05 AM EST
VIA GLOBENEWSWIRE
Iopofosine I 131 Featured in Two Separate Presentations at 12th International Workshop on Waldenstrom’s Macroglobulinemia
Cellectar Biosciences (NASDAQ: CLRB) announced two presentations on iopofosine I 131 at the 12th International Workshop on Waldenstrom's Macroglobulinemia in Prague.
The first presentation by Dr. Jorge Castillo will showcase a case study of complete central nervous system clearance in a patient with Bing-Neel Syndrome (BNS), a rare compli...
No comment yet